In assessing, GDP a nation is capable of measuring the health outcomes of public health expenditures based on health indicators such as life expectancy, under age five mortality rate, and adjusted capital spending on morbidity (Getzen, 2013; Shi & Singh, 2011). Thus, marks up the efficacy of the shared cost of public health efforts on reducing spend outcomes (Getzen, 2013; Shi & Singh, 2011). The US, a member of Organization for Economic Cooperation and Development (OECD), may have the newest medical technologies, but, has failed in many of the health indicators (Getzen, 2013; Peterson & Burton, 2007; Shi & Singh, 2011). The failure is perhaps due to system ineffectiveness to invest more in preventative health initiatives that would show a significant decrease rather than invest more in medical technologies that advert seeing a GDP (Getzen, 2013; Peterson & Burton,
In assessing, GDP a nation is capable of measuring the health outcomes of public health expenditures based on health indicators such as life expectancy, under age five mortality rate, and adjusted capital spending on morbidity (Getzen, 2013; Shi & Singh, 2011). Thus, marks up the efficacy of the shared cost of public health efforts on reducing spend outcomes (Getzen, 2013; Shi & Singh, 2011). The US, a member of Organization for Economic Cooperation and Development (OECD), may have the newest medical technologies, but, has failed in many of the health indicators (Getzen, 2013; Peterson & Burton, 2007; Shi & Singh, 2011). The failure is perhaps due to system ineffectiveness to invest more in preventative health initiatives that would show a significant decrease rather than invest more in medical technologies that advert seeing a GDP (Getzen, 2013; Peterson & Burton,